HIV Medicine

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
pp. 563-608(46)
Author: Gazzard, BG

Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome
pp. 609-615(7)
Authors: Curran, A; Falcó, V; Crespo, M; Martinez, X; Ribera, E; Villar del Saz, S; Imaz, A; Coma, E; Ferrer, A; Pahissa, A

Social and economic hardship among people living with HIV in London
pp. 616-624(9)
Authors: Ibrahim, F; Anderson, J; Bukutu, C; Elford, J

Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial
pp. 625-635(11)
Authors: Valantin, MA; Lanoy, E; Bentata, M; Kalmykova, O; Boutekadjirt, A; Allavena, C; Rozenbaum, W; Peytavin, G; Amellal, B; Calvez, V; Costagliola, D; Katlama, C

Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense
pp. 636-641(6)
Authors: Kitkungvan, D; Apisarnthanarak, A; Laowansiri, P; Mundy, LM

Prediction of phenotypic susceptibility to antiretroviral drugs using physiochemical properties of the primary enzymatic structure combined with artificial neural networks
pp. 642-652(11)
Authors: Kjær, J; Høj, L; Fox, Z; Lundgren, JD

Potential health risks of complementary alternative medicines in HIV patients
pp. 653-659(7)
Authors: Ladenheim, D; Horn, O; Werneke, U; Phillpot, M; Murungi, A; Theobald, N; Orkin, C

Effect of haematological alterations on thalassaemia investigation in HIV-1-infected Thai patients receiving antiretroviral therapy
pp. 660-666(7)
Authors: Pornprasert, S; Leechanachai, P; Klinbuayaem, V; Leenasirimakul, P; Sukunthamala, K; Thunjai, B; Phusua, A; Saetung, R; Sanguansermsri, T

Switching from twice-daily abacavir and lamivudine to the once-daily fixed-dose combination tablet of abacavir and lamivudine improves patient adherence and satisfaction with therapy
pp. 667-672(6)
Authors: Maitland, D; Jackson, A; Osorio, J; Mandalia, S; Gazzard, BG; Moyle, GJ

Genotypic antiretroviral drug resistance testing at low viral loads in the UK
pp. 673-676(4)
Authors: Cane, PA; Kaye, S; Smit, E; Tilston, P; Kirk, S; Shepherd, J; Hopkins, M; Zhang, H; Geretti, AM

The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia
pp. 677-680(4)
Authors: Pemberton, LA; Stone, E; Price, P; van Bockxmeer, F; Brew, BJ